| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.99▲ | 1.99▲ | 2.01▼ | 2.02▼ | 2.15▼ |
| MA10 | 1.99▲ | 2.02▼ | 2.02▼ | 2.08▼ | 2.09▼ |
| MA20 | 2.02▼ | 2.01▼ | 2.03▼ | 2.15▼ | 1.81▲ |
| MA50 | 2.02▼ | 2.01▼ | 2.05▼ | 2.05▼ | 1.34▲ |
| MA100 | 2.02▼ | 2.08▼ | 2.20▼ | 1.76▲ | N/A |
| MA200 | 2.01▲ | 2.19▼ | 2.07▼ | 1.37▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.003▼ | 0.002▲ | -0.034▼ | 0.002▲ |
| RSI | 48.454▼ | 48.707▼ | 46.703▼ | 45.649▼ | 58.465▲ |
| STOCH | 42.323 | 19.255▼ | 42.667 | 14.256▼ | 57.867 |
| WILL %R | -53.333 | -69.565 | -64.000 | -87.035▼ | -53.241 |
| CCI | 15.077 | -53.881 | -20.703 | -73.606 | 8.386 |
|
Tuesday, December 09, 2025 04:08 AM
Opus Genetics (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited ...
|
|
Friday, December 05, 2025 04:00 PM
Fintel reports that on December 10, 2025, B. Riley Securities initiated coverage of Opus Genetics (NasdaqCM:IRD) with a Buy recommendation. As of December 6, 2025, the average one-year price target ...
|
|
Friday, November 28, 2025 05:26 PM
On November 25, 2025, The Fly reported that Piper Sandler initiated coverage of Opus Genetics, Inc. (NASDAQ:IRD) with an “Overweight” rating and a $7 price target. The investment firm highlighted OPGx ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/12/25 | 2.03 | 2.03 | 1.975 | 2.01 | 30,441 |
| 24/12/25 | 2.02 | 2.09 | 1.985 | 2.04 | 148,902 |
| 23/12/25 | 2.06 | 2.06 | 1.9608 | 2.01 | 223,090 |
| 22/12/25 | 2.02 | 2.12 | 1.995 | 2.06 | 326,542 |
| 19/12/25 | 1.965 | 2.02 | 1.9235 | 2.00 | 442,208 |
| 18/12/25 | 2.02 | 2.0899 | 1.97 | 1.98 | 313,489 |
| 17/12/25 | 2.17 | 2.185 | 2.01 | 2.02 | 483,640 |
| 16/12/25 | 2.14 | 2.20 | 2.14 | 2.14 | 237,962 |
| 15/12/25 | 2.37 | 2.4169 | 2.13 | 2.13 | 362,583 |
| 12/12/25 | 2.43 | 2.50 | 2.3201 | 2.36 | 334,590 |
|
|
||||
|
|
||||
|
|